Global AI in Pharmaceutical Market Growth (Status and Outlook) 2026-2032
The global AI in Pharmaceutical market size is predicted to grow from US$ 10011 million in 2025 to US$ 26356 million in 2032; it is expected to grow at a CAGR of 16.6% from 2026 to 2032.
AI in Pharmaceutical refers to the application of artificial intelligence technologies, including machine learning, deep learning, natural language processing, computer vision, predictive analytics, and generative AI, across pharmaceutical research, drug discovery, clinical development, manufacturing, regulatory compliance, supply chain management, and commercial operations to improve efficiency, reduce development costs, accelerate drug commercialization, optimize decision-making, and enhance precision medicine capabilities within the pharmaceutical industry.
Current and planned AI in Pharmaceutical projects globally include large-scale AI drug discovery platforms, generative AI molecular design laboratories, pharmaceutical cloud computing infrastructure expansion projects, precision medicine analytics centers, AI-assisted clinical trial optimization programs, digital twin pharmaceutical manufacturing initiatives, intelligent biologics development facilities, collaborative AI-biotech research partnerships, pharmaceutical real-world data integration projects, automated regulatory compliance systems, AI-powered genomic medicine platforms, smart pharmaceutical supply chain management projects, AI-driven biomarker discovery programs, healthcare data lake construction projects, and advanced computational biology research centers intended to accelerate pharmaceutical innovation, reduce drug development timelines, improve clinical success rates, and strengthen data-driven healthcare commercialization capabilities worldwide.
2025 Global Market Average Gross Profit Margin: 58%.
The AI in Pharmaceutical market is experiencing rapid expansion as pharmaceutical companies increasingly adopt artificial intelligence technologies to improve drug discovery efficiency, reduce R&D costs, accelerate clinical development timelines, and enhance commercialization capabilities. Traditional pharmaceutical development processes are expensive, time-consuming, and characterized by high failure rates, creating strong demand for AI-driven predictive analytics and automation solutions. AI technologies are being widely integrated into molecular screening, biomarker discovery, target identification, toxicity prediction, and clinical trial optimization workflows. The growing availability of biomedical datasets, genomic sequencing technologies, cloud computing infrastructure, and high-performance computing resources has significantly accelerated AI adoption across the pharmaceutical sector. Generative AI models capable of designing novel molecular structures and simulating drug interactions are becoming increasingly important in next-generation pharmaceutical research strategies.
From a regional perspective, North America currently dominates the market due to strong pharmaceutical R&D investment, advanced digital infrastructure, abundant venture capital funding, and the presence of major AI and biotechnology companies. The United States represents the largest innovation hub for pharmaceutical AI development, supported by leading research institutions and strategic collaborations between pharmaceutical companies and AI startups. Europe maintains a strong market position driven by advanced healthcare systems, pharmaceutical manufacturing expertise, and increasing regulatory support for digital healthcare transformation. Asia-Pacific is emerging as the fastest-growing region due to expanding pharmaceutical manufacturing capacity, increasing healthcare digitization, government AI initiatives, and growing biotechnology investments in China, Japan, South Korea, and India. China is rapidly strengthening its position through large-scale healthcare data resources and aggressive AI commercialization programs.
The market presents substantial growth opportunities driven by increasing demand for precision medicine, personalized therapies, biologics development, and rare disease research. AI significantly reduces candidate screening timelines and improves drug development efficiency, making it highly attractive for pharmaceutical companies facing rising R&D expenditures and patent expiration pressures. The expansion of cloud-based AI platforms and AI-as-a-Service business models is lowering technology adoption barriers for small and mid-sized pharmaceutical firms. In addition, growing interest in decentralized clinical trials, digital therapeutics, and real-world evidence analytics is creating new application opportunities for pharmaceutical AI platforms. Strategic collaborations between pharmaceutical companies, AI developers, and healthcare institutions are expected to further accelerate innovation and commercialization.
LPI (LP Information)' newest research report, the ?AI in Pharmaceutical Industry Forecast? looks at past sales and reviews total world AI in Pharmaceutical sales in 2025, providing a comprehensive analysis by region and market sector of projected AI in Pharmaceutical sales for 2026 through 2032. With AI in Pharmaceutical sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI in Pharmaceutical industry.
This Insight Report provides a comprehensive analysis of the global AI in Pharmaceutical landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI in Pharmaceutical portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global AI in Pharmaceutical market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI in Pharmaceutical and breaks down the forecast by Deployment Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI in Pharmaceutical.
This report presents a comprehensive overview, market shares, and growth opportunities of AI in Pharmaceutical market by product type, application, key players and key regions and countries.
Segmentation by Deployment Type:
AI in Pharmaceutical refers to the application of artificial intelligence technologies, including machine learning, deep learning, natural language processing, computer vision, predictive analytics, and generative AI, across pharmaceutical research, drug discovery, clinical development, manufacturing, regulatory compliance, supply chain management, and commercial operations to improve efficiency, reduce development costs, accelerate drug commercialization, optimize decision-making, and enhance precision medicine capabilities within the pharmaceutical industry.
Current and planned AI in Pharmaceutical projects globally include large-scale AI drug discovery platforms, generative AI molecular design laboratories, pharmaceutical cloud computing infrastructure expansion projects, precision medicine analytics centers, AI-assisted clinical trial optimization programs, digital twin pharmaceutical manufacturing initiatives, intelligent biologics development facilities, collaborative AI-biotech research partnerships, pharmaceutical real-world data integration projects, automated regulatory compliance systems, AI-powered genomic medicine platforms, smart pharmaceutical supply chain management projects, AI-driven biomarker discovery programs, healthcare data lake construction projects, and advanced computational biology research centers intended to accelerate pharmaceutical innovation, reduce drug development timelines, improve clinical success rates, and strengthen data-driven healthcare commercialization capabilities worldwide.
2025 Global Market Average Gross Profit Margin: 58%.
The AI in Pharmaceutical market is experiencing rapid expansion as pharmaceutical companies increasingly adopt artificial intelligence technologies to improve drug discovery efficiency, reduce R&D costs, accelerate clinical development timelines, and enhance commercialization capabilities. Traditional pharmaceutical development processes are expensive, time-consuming, and characterized by high failure rates, creating strong demand for AI-driven predictive analytics and automation solutions. AI technologies are being widely integrated into molecular screening, biomarker discovery, target identification, toxicity prediction, and clinical trial optimization workflows. The growing availability of biomedical datasets, genomic sequencing technologies, cloud computing infrastructure, and high-performance computing resources has significantly accelerated AI adoption across the pharmaceutical sector. Generative AI models capable of designing novel molecular structures and simulating drug interactions are becoming increasingly important in next-generation pharmaceutical research strategies.
From a regional perspective, North America currently dominates the market due to strong pharmaceutical R&D investment, advanced digital infrastructure, abundant venture capital funding, and the presence of major AI and biotechnology companies. The United States represents the largest innovation hub for pharmaceutical AI development, supported by leading research institutions and strategic collaborations between pharmaceutical companies and AI startups. Europe maintains a strong market position driven by advanced healthcare systems, pharmaceutical manufacturing expertise, and increasing regulatory support for digital healthcare transformation. Asia-Pacific is emerging as the fastest-growing region due to expanding pharmaceutical manufacturing capacity, increasing healthcare digitization, government AI initiatives, and growing biotechnology investments in China, Japan, South Korea, and India. China is rapidly strengthening its position through large-scale healthcare data resources and aggressive AI commercialization programs.
The market presents substantial growth opportunities driven by increasing demand for precision medicine, personalized therapies, biologics development, and rare disease research. AI significantly reduces candidate screening timelines and improves drug development efficiency, making it highly attractive for pharmaceutical companies facing rising R&D expenditures and patent expiration pressures. The expansion of cloud-based AI platforms and AI-as-a-Service business models is lowering technology adoption barriers for small and mid-sized pharmaceutical firms. In addition, growing interest in decentralized clinical trials, digital therapeutics, and real-world evidence analytics is creating new application opportunities for pharmaceutical AI platforms. Strategic collaborations between pharmaceutical companies, AI developers, and healthcare institutions are expected to further accelerate innovation and commercialization.
LPI (LP Information)' newest research report, the ?AI in Pharmaceutical Industry Forecast? looks at past sales and reviews total world AI in Pharmaceutical sales in 2025, providing a comprehensive analysis by region and market sector of projected AI in Pharmaceutical sales for 2026 through 2032. With AI in Pharmaceutical sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI in Pharmaceutical industry.
This Insight Report provides a comprehensive analysis of the global AI in Pharmaceutical landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI in Pharmaceutical portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global AI in Pharmaceutical market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI in Pharmaceutical and breaks down the forecast by Deployment Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI in Pharmaceutical.
This report presents a comprehensive overview, market shares, and growth opportunities of AI in Pharmaceutical market by product type, application, key players and key regions and countries.
Segmentation by Deployment Type:
- Cloud-Based AI Solutions
- On-Premises AI Platforms
- Machine Learning AI
- Deep Learning AI
- Natural Language Processing (NLP)
- Computer Vision AI
- Others
- Drug Discovery AI Platforms
- Clinical Trial AI Systems
- Manufacturing Process AI
- Regulatory Compliance AI
- Others
- Drug Discovery and Design
- Biomarker Identification
- Clinical Trial Optimization
- Manufacturing Process Optimization
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Cradle
- Prezent
- Insilico Medicine
- Owkin, Inc
- Certara
- PathAI, Inc
- Aizon
- Salesforce, Inc
- Aidoc
- IQVIA
- ISOMORPHIC LABS
- ConcertAI
- Nexocode
- BenevolentAI
- Recursion
- Iktos
- XtalPi Inc
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global AI in Pharmaceutical Market Size (2021-2032)
2.1.2 AI in Pharmaceutical Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for AI in Pharmaceutical by Country/Region (2021, 2025 & 2032)
2.2 AI in Pharmaceutical Segment by Deployment Type
2.2.1 Cloud-Based AI Solutions
2.2.2 On-Premises AI Platforms
2.2.3 AI in Pharmaceutical Market Size by Deployment Type
2.2.3.1 AI in Pharmaceutical Market Size CAGR by Deployment Type (2021 VS 2025 VS 2032)
2.2.3.2 Global AI in Pharmaceutical Market Size Market Share by Deployment Type (2021-2026)
2.3 AI in Pharmaceutical Segment by Technology Type
2.3.1 Machine Learning AI
2.3.2 Deep Learning AI
2.3.3 Natural Language Processing (NLP)
2.3.4 Computer Vision AI
2.3.5 Others
2.3.6 AI in Pharmaceutical Market Size by Technology Type
2.3.6.1 AI in Pharmaceutical Market Size CAGR by Technology Type (2021 VS 2025 VS 2032)
2.3.6.2 Global AI in Pharmaceutical Market Size Market Share by Technology Type (2021-2026)
2.4 AI in Pharmaceutical Segment by Functional Integration Type
2.4.1 Drug Discovery AI Platforms
2.4.2 Clinical Trial AI Systems
2.4.3 Manufacturing Process AI
2.4.4 Regulatory Compliance AI
2.4.5 Others
2.4.6 AI in Pharmaceutical Market Size by Functional Integration Type
2.4.6.1 AI in Pharmaceutical Market Size CAGR by Functional Integration Type (2021 VS 2025 VS 2032)
2.4.6.2 Global AI in Pharmaceutical Market Size Market Share by Functional Integration Type (2021-2026)
2.5 AI in Pharmaceutical Segment by Application
2.5.1 Drug Discovery and Design
2.5.2 Biomarker Identification
2.5.3 Clinical Trial Optimization
2.5.4 Manufacturing Process Optimization
2.5.5 Others
2.5.6 AI in Pharmaceutical Market Size by Application
2.5.6.1 AI in Pharmaceutical Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.6.2 Global AI in Pharmaceutical Market Size Market Share by Application (2021-2026)
3 AI IN PHARMACEUTICAL MARKET SIZE BY PLAYER
3.1 AI in Pharmaceutical Market Size Market Share by Player
3.1.1 Global AI in Pharmaceutical Revenue by Player (2021-2026)
3.1.2 Global AI in Pharmaceutical Revenue Market Share by Player (2021-2026)
3.2 Global AI in Pharmaceutical Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI IN PHARMACEUTICAL BY REGION
4.1 AI in Pharmaceutical Market Size by Region (2021-2026)
4.2 Global AI in Pharmaceutical Annual Revenue by Country/Region (2021-2026)
4.3 Americas AI in Pharmaceutical Market Size Growth (2021-2026)
4.4 APAC AI in Pharmaceutical Market Size Growth (2021-2026)
4.5 Europe AI in Pharmaceutical Market Size Growth (2021-2026)
4.6 Middle East & Africa AI in Pharmaceutical Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas AI in Pharmaceutical Market Size by Country (2021-2026)
5.2 Americas AI in Pharmaceutical Market Size by Deployment Type (2021-2026)
5.3 Americas AI in Pharmaceutical Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI in Pharmaceutical Market Size by Region (2021-2026)
6.2 APAC AI in Pharmaceutical Market Size by Deployment Type (2021-2026)
6.3 APAC AI in Pharmaceutical Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe AI in Pharmaceutical Market Size by Country (2021-2026)
7.2 Europe AI in Pharmaceutical Market Size by Deployment Type (2021-2026)
7.3 Europe AI in Pharmaceutical Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa AI in Pharmaceutical by Region (2021-2026)
8.2 Middle East & Africa AI in Pharmaceutical Market Size by Deployment Type (2021-2026)
8.3 Middle East & Africa AI in Pharmaceutical Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AI IN PHARMACEUTICAL MARKET FORECAST
10.1 Global AI in Pharmaceutical Forecast by Region (2027-2032)
10.1.1 Global AI in Pharmaceutical Forecast by Region (2027-2032)
10.1.2 Americas AI in Pharmaceutical Forecast
10.1.3 APAC AI in Pharmaceutical Forecast
10.1.4 Europe AI in Pharmaceutical Forecast
10.1.5 Middle East & Africa AI in Pharmaceutical Forecast
10.2 Americas AI in Pharmaceutical Forecast by Country (2027-2032)
10.2.1 United States Market AI in Pharmaceutical Forecast
10.2.2 Canada Market AI in Pharmaceutical Forecast
10.2.3 Mexico Market AI in Pharmaceutical Forecast
10.2.4 Brazil Market AI in Pharmaceutical Forecast
10.3 APAC AI in Pharmaceutical Forecast by Region (2027-2032)
10.3.1 China AI in Pharmaceutical Market Forecast
10.3.2 Japan Market AI in Pharmaceutical Forecast
10.3.3 Korea Market AI in Pharmaceutical Forecast
10.3.4 Southeast Asia Market AI in Pharmaceutical Forecast
10.3.5 India Market AI in Pharmaceutical Forecast
10.3.6 Australia Market AI in Pharmaceutical Forecast
10.4 Europe AI in Pharmaceutical Forecast by Country (2027-2032)
10.4.1 Germany Market AI in Pharmaceutical Forecast
10.4.2 France Market AI in Pharmaceutical Forecast
10.4.3 UK Market AI in Pharmaceutical Forecast
10.4.4 Italy Market AI in Pharmaceutical Forecast
10.4.5 Russia Market AI in Pharmaceutical Forecast
10.5 Middle East & Africa AI in Pharmaceutical Forecast by Region (2027-2032)
10.5.1 Egypt Market AI in Pharmaceutical Forecast
10.5.2 South Africa Market AI in Pharmaceutical Forecast
10.5.3 Israel Market AI in Pharmaceutical Forecast
10.5.4 Turkey Market AI in Pharmaceutical Forecast
10.6 Global AI in Pharmaceutical Forecast by Deployment Type (2027-2032)
10.7 Global AI in Pharmaceutical Forecast by Application (2027-2032)
10.7.1 GCC Countries Market AI in Pharmaceutical Forecast
11 KEY PLAYERS ANALYSIS
11.1 Cradle
11.1.1 Cradle Company Information
11.1.2 Cradle AI in Pharmaceutical Product Offered
11.1.3 Cradle AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Cradle Main Business Overview
11.1.5 Cradle Latest Developments
11.2 Prezent
11.2.1 Prezent Company Information
11.2.2 Prezent AI in Pharmaceutical Product Offered
11.2.3 Prezent AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Prezent Main Business Overview
11.2.5 Prezent Latest Developments
11.3 Insilico Medicine
11.3.1 Insilico Medicine Company Information
11.3.2 Insilico Medicine AI in Pharmaceutical Product Offered
11.3.3 Insilico Medicine AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Insilico Medicine Main Business Overview
11.3.5 Insilico Medicine Latest Developments
11.4 Owkin, Inc
11.4.1 Owkin, Inc Company Information
11.4.2 Owkin, Inc AI in Pharmaceutical Product Offered
11.4.3 Owkin, Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Owkin, Inc Main Business Overview
11.4.5 Owkin, Inc Latest Developments
11.5 Certara
11.5.1 Certara Company Information
11.5.2 Certara AI in Pharmaceutical Product Offered
11.5.3 Certara AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Certara Main Business Overview
11.5.5 Certara Latest Developments
11.6 PathAI, Inc
11.6.1 PathAI, Inc Company Information
11.6.2 PathAI, Inc AI in Pharmaceutical Product Offered
11.6.3 PathAI, Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 PathAI, Inc Main Business Overview
11.6.5 PathAI, Inc Latest Developments
11.7 Aizon
11.7.1 Aizon Company Information
11.7.2 Aizon AI in Pharmaceutical Product Offered
11.7.3 Aizon AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Aizon Main Business Overview
11.7.5 Aizon Latest Developments
11.8 Salesforce, Inc
11.8.1 Salesforce, Inc Company Information
11.8.2 Salesforce, Inc AI in Pharmaceutical Product Offered
11.8.3 Salesforce, Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Salesforce, Inc Main Business Overview
11.8.5 Salesforce, Inc Latest Developments
11.9 Aidoc
11.9.1 Aidoc Company Information
11.9.2 Aidoc AI in Pharmaceutical Product Offered
11.9.3 Aidoc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Aidoc Main Business Overview
11.9.5 Aidoc Latest Developments
11.10 IQVIA
11.10.1 IQVIA Company Information
11.10.2 IQVIA AI in Pharmaceutical Product Offered
11.10.3 IQVIA AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 IQVIA Main Business Overview
11.10.5 IQVIA Latest Developments
11.11 ISOMORPHIC LABS
11.11.1 ISOMORPHIC LABS Company Information
11.11.2 ISOMORPHIC LABS AI in Pharmaceutical Product Offered
11.11.3 ISOMORPHIC LABS AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 ISOMORPHIC LABS Main Business Overview
11.11.5 ISOMORPHIC LABS Latest Developments
11.12 ConcertAI
11.12.1 ConcertAI Company Information
11.12.2 ConcertAI AI in Pharmaceutical Product Offered
11.12.3 ConcertAI AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 ConcertAI Main Business Overview
11.12.5 ConcertAI Latest Developments
11.13 Nexocode
11.13.1 Nexocode Company Information
11.13.2 Nexocode AI in Pharmaceutical Product Offered
11.13.3 Nexocode AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Nexocode Main Business Overview
11.13.5 Nexocode Latest Developments
11.14 BenevolentAI
11.14.1 BenevolentAI Company Information
11.14.2 BenevolentAI AI in Pharmaceutical Product Offered
11.14.3 BenevolentAI AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 BenevolentAI Main Business Overview
11.14.5 BenevolentAI Latest Developments
11.15 Recursion
11.15.1 Recursion Company Information
11.15.2 Recursion AI in Pharmaceutical Product Offered
11.15.3 Recursion AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Recursion Main Business Overview
11.15.5 Recursion Latest Developments
11.16 Iktos
11.16.1 Iktos Company Information
11.16.2 Iktos AI in Pharmaceutical Product Offered
11.16.3 Iktos AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Iktos Main Business Overview
11.16.5 Iktos Latest Developments
11.17 XtalPi Inc
11.17.1 XtalPi Inc Company Information
11.17.2 XtalPi Inc AI in Pharmaceutical Product Offered
11.17.3 XtalPi Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 XtalPi Inc Main Business Overview
11.17.5 XtalPi Inc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global AI in Pharmaceutical Market Size (2021-2032)
2.1.2 AI in Pharmaceutical Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for AI in Pharmaceutical by Country/Region (2021, 2025 & 2032)
2.2 AI in Pharmaceutical Segment by Deployment Type
2.2.1 Cloud-Based AI Solutions
2.2.2 On-Premises AI Platforms
2.2.3 AI in Pharmaceutical Market Size by Deployment Type
2.2.3.1 AI in Pharmaceutical Market Size CAGR by Deployment Type (2021 VS 2025 VS 2032)
2.2.3.2 Global AI in Pharmaceutical Market Size Market Share by Deployment Type (2021-2026)
2.3 AI in Pharmaceutical Segment by Technology Type
2.3.1 Machine Learning AI
2.3.2 Deep Learning AI
2.3.3 Natural Language Processing (NLP)
2.3.4 Computer Vision AI
2.3.5 Others
2.3.6 AI in Pharmaceutical Market Size by Technology Type
2.3.6.1 AI in Pharmaceutical Market Size CAGR by Technology Type (2021 VS 2025 VS 2032)
2.3.6.2 Global AI in Pharmaceutical Market Size Market Share by Technology Type (2021-2026)
2.4 AI in Pharmaceutical Segment by Functional Integration Type
2.4.1 Drug Discovery AI Platforms
2.4.2 Clinical Trial AI Systems
2.4.3 Manufacturing Process AI
2.4.4 Regulatory Compliance AI
2.4.5 Others
2.4.6 AI in Pharmaceutical Market Size by Functional Integration Type
2.4.6.1 AI in Pharmaceutical Market Size CAGR by Functional Integration Type (2021 VS 2025 VS 2032)
2.4.6.2 Global AI in Pharmaceutical Market Size Market Share by Functional Integration Type (2021-2026)
2.5 AI in Pharmaceutical Segment by Application
2.5.1 Drug Discovery and Design
2.5.2 Biomarker Identification
2.5.3 Clinical Trial Optimization
2.5.4 Manufacturing Process Optimization
2.5.5 Others
2.5.6 AI in Pharmaceutical Market Size by Application
2.5.6.1 AI in Pharmaceutical Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.6.2 Global AI in Pharmaceutical Market Size Market Share by Application (2021-2026)
3 AI IN PHARMACEUTICAL MARKET SIZE BY PLAYER
3.1 AI in Pharmaceutical Market Size Market Share by Player
3.1.1 Global AI in Pharmaceutical Revenue by Player (2021-2026)
3.1.2 Global AI in Pharmaceutical Revenue Market Share by Player (2021-2026)
3.2 Global AI in Pharmaceutical Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI IN PHARMACEUTICAL BY REGION
4.1 AI in Pharmaceutical Market Size by Region (2021-2026)
4.2 Global AI in Pharmaceutical Annual Revenue by Country/Region (2021-2026)
4.3 Americas AI in Pharmaceutical Market Size Growth (2021-2026)
4.4 APAC AI in Pharmaceutical Market Size Growth (2021-2026)
4.5 Europe AI in Pharmaceutical Market Size Growth (2021-2026)
4.6 Middle East & Africa AI in Pharmaceutical Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas AI in Pharmaceutical Market Size by Country (2021-2026)
5.2 Americas AI in Pharmaceutical Market Size by Deployment Type (2021-2026)
5.3 Americas AI in Pharmaceutical Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI in Pharmaceutical Market Size by Region (2021-2026)
6.2 APAC AI in Pharmaceutical Market Size by Deployment Type (2021-2026)
6.3 APAC AI in Pharmaceutical Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe AI in Pharmaceutical Market Size by Country (2021-2026)
7.2 Europe AI in Pharmaceutical Market Size by Deployment Type (2021-2026)
7.3 Europe AI in Pharmaceutical Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa AI in Pharmaceutical by Region (2021-2026)
8.2 Middle East & Africa AI in Pharmaceutical Market Size by Deployment Type (2021-2026)
8.3 Middle East & Africa AI in Pharmaceutical Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AI IN PHARMACEUTICAL MARKET FORECAST
10.1 Global AI in Pharmaceutical Forecast by Region (2027-2032)
10.1.1 Global AI in Pharmaceutical Forecast by Region (2027-2032)
10.1.2 Americas AI in Pharmaceutical Forecast
10.1.3 APAC AI in Pharmaceutical Forecast
10.1.4 Europe AI in Pharmaceutical Forecast
10.1.5 Middle East & Africa AI in Pharmaceutical Forecast
10.2 Americas AI in Pharmaceutical Forecast by Country (2027-2032)
10.2.1 United States Market AI in Pharmaceutical Forecast
10.2.2 Canada Market AI in Pharmaceutical Forecast
10.2.3 Mexico Market AI in Pharmaceutical Forecast
10.2.4 Brazil Market AI in Pharmaceutical Forecast
10.3 APAC AI in Pharmaceutical Forecast by Region (2027-2032)
10.3.1 China AI in Pharmaceutical Market Forecast
10.3.2 Japan Market AI in Pharmaceutical Forecast
10.3.3 Korea Market AI in Pharmaceutical Forecast
10.3.4 Southeast Asia Market AI in Pharmaceutical Forecast
10.3.5 India Market AI in Pharmaceutical Forecast
10.3.6 Australia Market AI in Pharmaceutical Forecast
10.4 Europe AI in Pharmaceutical Forecast by Country (2027-2032)
10.4.1 Germany Market AI in Pharmaceutical Forecast
10.4.2 France Market AI in Pharmaceutical Forecast
10.4.3 UK Market AI in Pharmaceutical Forecast
10.4.4 Italy Market AI in Pharmaceutical Forecast
10.4.5 Russia Market AI in Pharmaceutical Forecast
10.5 Middle East & Africa AI in Pharmaceutical Forecast by Region (2027-2032)
10.5.1 Egypt Market AI in Pharmaceutical Forecast
10.5.2 South Africa Market AI in Pharmaceutical Forecast
10.5.3 Israel Market AI in Pharmaceutical Forecast
10.5.4 Turkey Market AI in Pharmaceutical Forecast
10.6 Global AI in Pharmaceutical Forecast by Deployment Type (2027-2032)
10.7 Global AI in Pharmaceutical Forecast by Application (2027-2032)
10.7.1 GCC Countries Market AI in Pharmaceutical Forecast
11 KEY PLAYERS ANALYSIS
11.1 Cradle
11.1.1 Cradle Company Information
11.1.2 Cradle AI in Pharmaceutical Product Offered
11.1.3 Cradle AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Cradle Main Business Overview
11.1.5 Cradle Latest Developments
11.2 Prezent
11.2.1 Prezent Company Information
11.2.2 Prezent AI in Pharmaceutical Product Offered
11.2.3 Prezent AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Prezent Main Business Overview
11.2.5 Prezent Latest Developments
11.3 Insilico Medicine
11.3.1 Insilico Medicine Company Information
11.3.2 Insilico Medicine AI in Pharmaceutical Product Offered
11.3.3 Insilico Medicine AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Insilico Medicine Main Business Overview
11.3.5 Insilico Medicine Latest Developments
11.4 Owkin, Inc
11.4.1 Owkin, Inc Company Information
11.4.2 Owkin, Inc AI in Pharmaceutical Product Offered
11.4.3 Owkin, Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Owkin, Inc Main Business Overview
11.4.5 Owkin, Inc Latest Developments
11.5 Certara
11.5.1 Certara Company Information
11.5.2 Certara AI in Pharmaceutical Product Offered
11.5.3 Certara AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Certara Main Business Overview
11.5.5 Certara Latest Developments
11.6 PathAI, Inc
11.6.1 PathAI, Inc Company Information
11.6.2 PathAI, Inc AI in Pharmaceutical Product Offered
11.6.3 PathAI, Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 PathAI, Inc Main Business Overview
11.6.5 PathAI, Inc Latest Developments
11.7 Aizon
11.7.1 Aizon Company Information
11.7.2 Aizon AI in Pharmaceutical Product Offered
11.7.3 Aizon AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Aizon Main Business Overview
11.7.5 Aizon Latest Developments
11.8 Salesforce, Inc
11.8.1 Salesforce, Inc Company Information
11.8.2 Salesforce, Inc AI in Pharmaceutical Product Offered
11.8.3 Salesforce, Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Salesforce, Inc Main Business Overview
11.8.5 Salesforce, Inc Latest Developments
11.9 Aidoc
11.9.1 Aidoc Company Information
11.9.2 Aidoc AI in Pharmaceutical Product Offered
11.9.3 Aidoc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Aidoc Main Business Overview
11.9.5 Aidoc Latest Developments
11.10 IQVIA
11.10.1 IQVIA Company Information
11.10.2 IQVIA AI in Pharmaceutical Product Offered
11.10.3 IQVIA AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 IQVIA Main Business Overview
11.10.5 IQVIA Latest Developments
11.11 ISOMORPHIC LABS
11.11.1 ISOMORPHIC LABS Company Information
11.11.2 ISOMORPHIC LABS AI in Pharmaceutical Product Offered
11.11.3 ISOMORPHIC LABS AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 ISOMORPHIC LABS Main Business Overview
11.11.5 ISOMORPHIC LABS Latest Developments
11.12 ConcertAI
11.12.1 ConcertAI Company Information
11.12.2 ConcertAI AI in Pharmaceutical Product Offered
11.12.3 ConcertAI AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 ConcertAI Main Business Overview
11.12.5 ConcertAI Latest Developments
11.13 Nexocode
11.13.1 Nexocode Company Information
11.13.2 Nexocode AI in Pharmaceutical Product Offered
11.13.3 Nexocode AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Nexocode Main Business Overview
11.13.5 Nexocode Latest Developments
11.14 BenevolentAI
11.14.1 BenevolentAI Company Information
11.14.2 BenevolentAI AI in Pharmaceutical Product Offered
11.14.3 BenevolentAI AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 BenevolentAI Main Business Overview
11.14.5 BenevolentAI Latest Developments
11.15 Recursion
11.15.1 Recursion Company Information
11.15.2 Recursion AI in Pharmaceutical Product Offered
11.15.3 Recursion AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Recursion Main Business Overview
11.15.5 Recursion Latest Developments
11.16 Iktos
11.16.1 Iktos Company Information
11.16.2 Iktos AI in Pharmaceutical Product Offered
11.16.3 Iktos AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Iktos Main Business Overview
11.16.5 Iktos Latest Developments
11.17 XtalPi Inc
11.17.1 XtalPi Inc Company Information
11.17.2 XtalPi Inc AI in Pharmaceutical Product Offered
11.17.3 XtalPi Inc AI in Pharmaceutical Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 XtalPi Inc Main Business Overview
11.17.5 XtalPi Inc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. AI in Pharmaceutical Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. AI in Pharmaceutical Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cloud-Based AI Solutions
Table 4. Major Players of On-Premises AI Platforms
Table 5. AI in Pharmaceutical Market Size CAGR by Deployment Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global AI in Pharmaceutical Market Size by Deployment Type (2021-2026) & ($ millions)
Table 7. Global AI in Pharmaceutical Market Size Market Share by Deployment Type (2021-2026)
Table 8. Major Players of Machine Learning AI
Table 9. Major Players of Deep Learning AI
Table 10. Major Players of Natural Language Processing (NLP)
Table 11. Major Players of Computer Vision AI
Table 12. Major Players of Others
Table 13. AI in Pharmaceutical Market Size CAGR by Technology Type (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global AI in Pharmaceutical Market Size by Technology Type (2021-2026) & ($ millions)
Table 15. Global AI in Pharmaceutical Market Size Market Share by Technology Type (2021-2026)
Table 16. Major Players of Drug Discovery AI Platforms
Table 17. Major Players of Clinical Trial AI Systems
Table 18. Major Players of Manufacturing Process AI
Table 19. Major Players of Regulatory Compliance AI
Table 20. Major Players of Others
Table 21. AI in Pharmaceutical Market Size CAGR by Functional Integration Type (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global AI in Pharmaceutical Market Size by Functional Integration Type (2021-2026) & ($ millions)
Table 23. Global AI in Pharmaceutical Market Size Market Share by Functional Integration Type (2021-2026)
Table 24. AI in Pharmaceutical Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 25. Global AI in Pharmaceutical Market Size by Application (2021-2026) & ($ millions)
Table 26. Global AI in Pharmaceutical Market Size Market Share by Application (2021-2026)
Table 27. Global AI in Pharmaceutical Revenue by Player (2021-2026) & ($ millions)
Table 28. Global AI in Pharmaceutical Revenue Market Share by Player (2021-2026)
Table 29. AI in Pharmaceutical Key Players Head office and Products Offered
Table 30. AI in Pharmaceutical Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Mergers & Acquisitions, Expansion
Table 33. Global AI in Pharmaceutical Market Size by Region (2021-2026) & ($ millions)
Table 34. Global AI in Pharmaceutical Market Size Market Share by Region (2021-2026)
Table 35. Global AI in Pharmaceutical Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global AI in Pharmaceutical Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas AI in Pharmaceutical Market Size by Country (2021-2026) & ($ millions)
Table 38. Americas AI in Pharmaceutical Market Size Market Share by Country (2021-2026)
Table 39. Americas AI in Pharmaceutical Market Size by Deployment Type (2021-2026) & ($ millions)
Table 40. Americas AI in Pharmaceutical Market Size Market Share by Deployment Type (2021-2026)
Table 41. Americas AI in Pharmaceutical Market Size by Application (2021-2026) & ($ millions)
Table 42. Americas AI in Pharmaceutical Market Size Market Share by Application (2021-2026)
Table 43. APAC AI in Pharmaceutical Market Size by Region (2021-2026) & ($ millions)
Table 44. APAC AI in Pharmaceutical Market Size Market Share by Region (2021-2026)
Table 45. APAC AI in Pharmaceutical Market Size by Deployment Type (2021-2026) & ($ millions)
Table 46. APAC AI in Pharmaceutical Market Size by Application (2021-2026) & ($ millions)
Table 47. Europe AI in Pharmaceutical Market Size by Country (2021-2026) & ($ millions)
Table 48. Europe AI in Pharmaceutical Market Size Market Share by Country (2021-2026)
Table 49. Europe AI in Pharmaceutical Market Size by Deployment Type (2021-2026) & ($ millions)
Table 50. Europe AI in Pharmaceutical Market Size by Application (2021-2026) & ($ millions)
Table 51. Middle East & Africa AI in Pharmaceutical Market Size by Region (2021-2026) & ($ millions)
Table 52. Middle East & Africa AI in Pharmaceutical Market Size by Deployment Type (2021-2026) & ($ millions)
Table 53. Middle East & Africa AI in Pharmaceutical Market Size by Application (2021-2026) & ($ millions)
Table 54. Key Market Drivers & Growth Opportunities of AI in Pharmaceutical
Table 55. Key Market Challenges & Risks of AI in Pharmaceutical
Table 56. Key Industry Trends of AI in Pharmaceutical
Table 57. Global AI in Pharmaceutical Market Size Forecast by Region (2027-2032) & ($ millions)
Table 58. Global AI in Pharmaceutical Market Size Market Share Forecast by Region (2027-2032)
Table 59. Global AI in Pharmaceutical Market Size Forecast by Deployment Type (2027-2032) & ($ millions)
Table 60. Global AI in Pharmaceutical Market Size Forecast by Application (2027-2032) & ($ millions)
Table 61. Cradle Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 62. Cradle AI in Pharmaceutical Product Offered
Table 63. Cradle AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Cradle Main Business
Table 65. Cradle Latest Developments
Table 66. Prezent Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 67. Prezent AI in Pharmaceutical Product Offered
Table 68. Prezent AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Prezent Main Business
Table 70. Prezent Latest Developments
Table 71. Insilico Medicine Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 72. Insilico Medicine AI in Pharmaceutical Product Offered
Table 73. Insilico Medicine AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Insilico Medicine Main Business
Table 75. Insilico Medicine Latest Developments
Table 76. Owkin, Inc Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 77. Owkin, Inc AI in Pharmaceutical Product Offered
Table 78. Owkin, Inc AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Owkin, Inc Main Business
Table 80. Owkin, Inc Latest Developments
Table 81. Certara Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 82. Certara AI in Pharmaceutical Product Offered
Table 83. Certara AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Certara Main Business
Table 85. Certara Latest Developments
Table 86. PathAI, Inc Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 87. PathAI, Inc AI in Pharmaceutical Product Offered
Table 88. PathAI, Inc AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. PathAI, Inc Main Business
Table 90. PathAI, Inc Latest Developments
Table 91. Aizon Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 92. Aizon AI in Pharmaceutical Product Offered
Table 93. Aizon AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Aizon Main Business
Table 95. Aizon Latest Developments
Table 96. Salesforce, Inc Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 97. Salesforce, Inc AI in Pharmaceutical Product Offered
Table 98. Salesforce, Inc AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Salesforce, Inc Main Business
Table 100. Salesforce, Inc Latest Developments
Table 101. Aidoc Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 102. Aidoc AI in Pharmaceutical Product Offered
Table 103. Aidoc AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Aidoc Main Business
Table 105. Aidoc Latest Developments
Table 106. IQVIA Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 107. IQVIA AI in Pharmaceutical Product Offered
Table 108. IQVIA AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. IQVIA Main Business
Table 110. IQVIA Latest Developments
Table 111. ISOMORPHIC LABS Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 112. ISOMORPHIC LABS AI in Pharmaceutical Product Offered
Table 113. ISOMORPHIC LABS AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. ISOMORPHIC LABS Main Business
Table 115. ISOMORPHIC LABS Latest Developments
Table 116. ConcertAI Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 117. ConcertAI AI in Pharmaceutical Product Offered
Table 118. ConcertAI AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. ConcertAI Main Business
Table 120. ConcertAI Latest Developments
Table 121. Nexocode Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 122. Nexocode AI in Pharmaceutical Product Offered
Table 123. Nexocode AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Nexocode Main Business
Table 125. Nexocode Latest Developments
Table 126. BenevolentAI Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 127. BenevolentAI AI in Pharmaceutical Product Offered
Table 128. BenevolentAI AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. BenevolentAI Main Business
Table 130. BenevolentAI Latest Developments
Table 131. Recursion Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 132. Recursion AI in Pharmaceutical Product Offered
Table 133. Recursion AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Recursion Main Business
Table 135. Recursion Latest Developments
Table 136. Iktos Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 137. Iktos AI in Pharmaceutical Product Offered
Table 138. Iktos AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Iktos Main Business
Table 140. Iktos Latest Developments
Table 141. XtalPi Inc Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 142. XtalPi Inc AI in Pharmaceutical Product Offered
Table 143. XtalPi Inc AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. XtalPi Inc Main Business
Table 145. XtalPi Inc Latest Developments
Table 1. AI in Pharmaceutical Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. AI in Pharmaceutical Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cloud-Based AI Solutions
Table 4. Major Players of On-Premises AI Platforms
Table 5. AI in Pharmaceutical Market Size CAGR by Deployment Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global AI in Pharmaceutical Market Size by Deployment Type (2021-2026) & ($ millions)
Table 7. Global AI in Pharmaceutical Market Size Market Share by Deployment Type (2021-2026)
Table 8. Major Players of Machine Learning AI
Table 9. Major Players of Deep Learning AI
Table 10. Major Players of Natural Language Processing (NLP)
Table 11. Major Players of Computer Vision AI
Table 12. Major Players of Others
Table 13. AI in Pharmaceutical Market Size CAGR by Technology Type (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global AI in Pharmaceutical Market Size by Technology Type (2021-2026) & ($ millions)
Table 15. Global AI in Pharmaceutical Market Size Market Share by Technology Type (2021-2026)
Table 16. Major Players of Drug Discovery AI Platforms
Table 17. Major Players of Clinical Trial AI Systems
Table 18. Major Players of Manufacturing Process AI
Table 19. Major Players of Regulatory Compliance AI
Table 20. Major Players of Others
Table 21. AI in Pharmaceutical Market Size CAGR by Functional Integration Type (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global AI in Pharmaceutical Market Size by Functional Integration Type (2021-2026) & ($ millions)
Table 23. Global AI in Pharmaceutical Market Size Market Share by Functional Integration Type (2021-2026)
Table 24. AI in Pharmaceutical Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 25. Global AI in Pharmaceutical Market Size by Application (2021-2026) & ($ millions)
Table 26. Global AI in Pharmaceutical Market Size Market Share by Application (2021-2026)
Table 27. Global AI in Pharmaceutical Revenue by Player (2021-2026) & ($ millions)
Table 28. Global AI in Pharmaceutical Revenue Market Share by Player (2021-2026)
Table 29. AI in Pharmaceutical Key Players Head office and Products Offered
Table 30. AI in Pharmaceutical Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Mergers & Acquisitions, Expansion
Table 33. Global AI in Pharmaceutical Market Size by Region (2021-2026) & ($ millions)
Table 34. Global AI in Pharmaceutical Market Size Market Share by Region (2021-2026)
Table 35. Global AI in Pharmaceutical Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global AI in Pharmaceutical Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas AI in Pharmaceutical Market Size by Country (2021-2026) & ($ millions)
Table 38. Americas AI in Pharmaceutical Market Size Market Share by Country (2021-2026)
Table 39. Americas AI in Pharmaceutical Market Size by Deployment Type (2021-2026) & ($ millions)
Table 40. Americas AI in Pharmaceutical Market Size Market Share by Deployment Type (2021-2026)
Table 41. Americas AI in Pharmaceutical Market Size by Application (2021-2026) & ($ millions)
Table 42. Americas AI in Pharmaceutical Market Size Market Share by Application (2021-2026)
Table 43. APAC AI in Pharmaceutical Market Size by Region (2021-2026) & ($ millions)
Table 44. APAC AI in Pharmaceutical Market Size Market Share by Region (2021-2026)
Table 45. APAC AI in Pharmaceutical Market Size by Deployment Type (2021-2026) & ($ millions)
Table 46. APAC AI in Pharmaceutical Market Size by Application (2021-2026) & ($ millions)
Table 47. Europe AI in Pharmaceutical Market Size by Country (2021-2026) & ($ millions)
Table 48. Europe AI in Pharmaceutical Market Size Market Share by Country (2021-2026)
Table 49. Europe AI in Pharmaceutical Market Size by Deployment Type (2021-2026) & ($ millions)
Table 50. Europe AI in Pharmaceutical Market Size by Application (2021-2026) & ($ millions)
Table 51. Middle East & Africa AI in Pharmaceutical Market Size by Region (2021-2026) & ($ millions)
Table 52. Middle East & Africa AI in Pharmaceutical Market Size by Deployment Type (2021-2026) & ($ millions)
Table 53. Middle East & Africa AI in Pharmaceutical Market Size by Application (2021-2026) & ($ millions)
Table 54. Key Market Drivers & Growth Opportunities of AI in Pharmaceutical
Table 55. Key Market Challenges & Risks of AI in Pharmaceutical
Table 56. Key Industry Trends of AI in Pharmaceutical
Table 57. Global AI in Pharmaceutical Market Size Forecast by Region (2027-2032) & ($ millions)
Table 58. Global AI in Pharmaceutical Market Size Market Share Forecast by Region (2027-2032)
Table 59. Global AI in Pharmaceutical Market Size Forecast by Deployment Type (2027-2032) & ($ millions)
Table 60. Global AI in Pharmaceutical Market Size Forecast by Application (2027-2032) & ($ millions)
Table 61. Cradle Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 62. Cradle AI in Pharmaceutical Product Offered
Table 63. Cradle AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Cradle Main Business
Table 65. Cradle Latest Developments
Table 66. Prezent Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 67. Prezent AI in Pharmaceutical Product Offered
Table 68. Prezent AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Prezent Main Business
Table 70. Prezent Latest Developments
Table 71. Insilico Medicine Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 72. Insilico Medicine AI in Pharmaceutical Product Offered
Table 73. Insilico Medicine AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Insilico Medicine Main Business
Table 75. Insilico Medicine Latest Developments
Table 76. Owkin, Inc Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 77. Owkin, Inc AI in Pharmaceutical Product Offered
Table 78. Owkin, Inc AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Owkin, Inc Main Business
Table 80. Owkin, Inc Latest Developments
Table 81. Certara Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 82. Certara AI in Pharmaceutical Product Offered
Table 83. Certara AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Certara Main Business
Table 85. Certara Latest Developments
Table 86. PathAI, Inc Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 87. PathAI, Inc AI in Pharmaceutical Product Offered
Table 88. PathAI, Inc AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. PathAI, Inc Main Business
Table 90. PathAI, Inc Latest Developments
Table 91. Aizon Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 92. Aizon AI in Pharmaceutical Product Offered
Table 93. Aizon AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Aizon Main Business
Table 95. Aizon Latest Developments
Table 96. Salesforce, Inc Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 97. Salesforce, Inc AI in Pharmaceutical Product Offered
Table 98. Salesforce, Inc AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Salesforce, Inc Main Business
Table 100. Salesforce, Inc Latest Developments
Table 101. Aidoc Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 102. Aidoc AI in Pharmaceutical Product Offered
Table 103. Aidoc AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Aidoc Main Business
Table 105. Aidoc Latest Developments
Table 106. IQVIA Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 107. IQVIA AI in Pharmaceutical Product Offered
Table 108. IQVIA AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. IQVIA Main Business
Table 110. IQVIA Latest Developments
Table 111. ISOMORPHIC LABS Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 112. ISOMORPHIC LABS AI in Pharmaceutical Product Offered
Table 113. ISOMORPHIC LABS AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. ISOMORPHIC LABS Main Business
Table 115. ISOMORPHIC LABS Latest Developments
Table 116. ConcertAI Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 117. ConcertAI AI in Pharmaceutical Product Offered
Table 118. ConcertAI AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. ConcertAI Main Business
Table 120. ConcertAI Latest Developments
Table 121. Nexocode Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 122. Nexocode AI in Pharmaceutical Product Offered
Table 123. Nexocode AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Nexocode Main Business
Table 125. Nexocode Latest Developments
Table 126. BenevolentAI Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 127. BenevolentAI AI in Pharmaceutical Product Offered
Table 128. BenevolentAI AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. BenevolentAI Main Business
Table 130. BenevolentAI Latest Developments
Table 131. Recursion Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 132. Recursion AI in Pharmaceutical Product Offered
Table 133. Recursion AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Recursion Main Business
Table 135. Recursion Latest Developments
Table 136. Iktos Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 137. Iktos AI in Pharmaceutical Product Offered
Table 138. Iktos AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Iktos Main Business
Table 140. Iktos Latest Developments
Table 141. XtalPi Inc Details, Company Type, AI in Pharmaceutical Area Served and Its Competitors
Table 142. XtalPi Inc AI in Pharmaceutical Product Offered
Table 143. XtalPi Inc AI in Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. XtalPi Inc Main Business
Table 145. XtalPi Inc Latest Developments
LIST OF FIGURES
Figure 1. AI in Pharmaceutical Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global AI in Pharmaceutical Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. AI in Pharmaceutical Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. AI in Pharmaceutical Sales Market Share by Country/Region (2025)
Figure 8. AI in Pharmaceutical Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global AI in Pharmaceutical Market Size Market Share by Deployment Type in 2025
Figure 10. Global AI in Pharmaceutical Market Size Market Share by Technology Type in 2025
Figure 11. Global AI in Pharmaceutical Market Size Market Share by Functional Integration Type in 2025
Figure 12. AI in Pharmaceutical in Drug Discovery and Design
Figure 13. Global AI in Pharmaceutical Market: Drug Discovery and Design (2021-2026) & ($ millions)
Figure 14. AI in Pharmaceutical in Biomarker Identification
Figure 15. Global AI in Pharmaceutical Market: Biomarker Identification (2021-2026) & ($ millions)
Figure 16. AI in Pharmaceutical in Clinical Trial Optimization
Figure 17. Global AI in Pharmaceutical Market: Clinical Trial Optimization (2021-2026) & ($ millions)
Figure 18. AI in Pharmaceutical in Manufacturing Process Optimization
Figure 19. Global AI in Pharmaceutical Market: Manufacturing Process Optimization (2021-2026) & ($ millions)
Figure 20. AI in Pharmaceutical in Others
Figure 21. Global AI in Pharmaceutical Market: Others (2021-2026) & ($ millions)
Figure 22. Global AI in Pharmaceutical Market Size Market Share by Application in 2025
Figure 23. Global AI in Pharmaceutical Revenue Market Share by Player in 2025
Figure 24. Global AI in Pharmaceutical Market Size Market Share by Region (2021-2026)
Figure 25. Americas AI in Pharmaceutical Market Size 2021-2026 ($ millions)
Figure 26. APAC AI in Pharmaceutical Market Size 2021-2026 ($ millions)
Figure 27. Europe AI in Pharmaceutical Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa AI in Pharmaceutical Market Size 2021-2026 ($ millions)
Figure 29. Americas AI in Pharmaceutical Value Market Share by Country in 2025
Figure 30. United States AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC AI in Pharmaceutical Market Size Market Share by Region in 2025
Figure 35. APAC AI in Pharmaceutical Market Size Market Share by Deployment Type (2021-2026)
Figure 36. APAC AI in Pharmaceutical Market Size Market Share by Application (2021-2026)
Figure 37. China AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 41. India AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe AI in Pharmaceutical Market Size Market Share by Country in 2025
Figure 44. Europe AI in Pharmaceutical Market Size Market Share by Deployment Type (2021-2026)
Figure 45. Europe AI in Pharmaceutical Market Size Market Share by Application (2021-2026)
Figure 46. Germany AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 47. France AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 48. UK AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa AI in Pharmaceutical Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa AI in Pharmaceutical Market Size Market Share by Deployment Type (2021-2026)
Figure 53. Middle East & Africa AI in Pharmaceutical Market Size Market Share by Application (2021-2026)
Figure 54. Egypt AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 60. APAC AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 61. Europe AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 63. United States AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 64. Canada AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 65. Mexico AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 66. Brazil AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 67. China AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 68. Japan AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 69. Korea AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 71. India AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 72. Australia AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 73. Germany AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 74. France AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 75. UK AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 76. Italy AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 77. Russia AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 78. Egypt AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 79. South Africa AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 80. Israel AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 81. Turkey AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 82. Global AI in Pharmaceutical Market Size Market Share Forecast by Deployment Type (2027-2032)
Figure 83. Global AI in Pharmaceutical Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 1. AI in Pharmaceutical Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global AI in Pharmaceutical Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. AI in Pharmaceutical Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. AI in Pharmaceutical Sales Market Share by Country/Region (2025)
Figure 8. AI in Pharmaceutical Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global AI in Pharmaceutical Market Size Market Share by Deployment Type in 2025
Figure 10. Global AI in Pharmaceutical Market Size Market Share by Technology Type in 2025
Figure 11. Global AI in Pharmaceutical Market Size Market Share by Functional Integration Type in 2025
Figure 12. AI in Pharmaceutical in Drug Discovery and Design
Figure 13. Global AI in Pharmaceutical Market: Drug Discovery and Design (2021-2026) & ($ millions)
Figure 14. AI in Pharmaceutical in Biomarker Identification
Figure 15. Global AI in Pharmaceutical Market: Biomarker Identification (2021-2026) & ($ millions)
Figure 16. AI in Pharmaceutical in Clinical Trial Optimization
Figure 17. Global AI in Pharmaceutical Market: Clinical Trial Optimization (2021-2026) & ($ millions)
Figure 18. AI in Pharmaceutical in Manufacturing Process Optimization
Figure 19. Global AI in Pharmaceutical Market: Manufacturing Process Optimization (2021-2026) & ($ millions)
Figure 20. AI in Pharmaceutical in Others
Figure 21. Global AI in Pharmaceutical Market: Others (2021-2026) & ($ millions)
Figure 22. Global AI in Pharmaceutical Market Size Market Share by Application in 2025
Figure 23. Global AI in Pharmaceutical Revenue Market Share by Player in 2025
Figure 24. Global AI in Pharmaceutical Market Size Market Share by Region (2021-2026)
Figure 25. Americas AI in Pharmaceutical Market Size 2021-2026 ($ millions)
Figure 26. APAC AI in Pharmaceutical Market Size 2021-2026 ($ millions)
Figure 27. Europe AI in Pharmaceutical Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa AI in Pharmaceutical Market Size 2021-2026 ($ millions)
Figure 29. Americas AI in Pharmaceutical Value Market Share by Country in 2025
Figure 30. United States AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC AI in Pharmaceutical Market Size Market Share by Region in 2025
Figure 35. APAC AI in Pharmaceutical Market Size Market Share by Deployment Type (2021-2026)
Figure 36. APAC AI in Pharmaceutical Market Size Market Share by Application (2021-2026)
Figure 37. China AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 41. India AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe AI in Pharmaceutical Market Size Market Share by Country in 2025
Figure 44. Europe AI in Pharmaceutical Market Size Market Share by Deployment Type (2021-2026)
Figure 45. Europe AI in Pharmaceutical Market Size Market Share by Application (2021-2026)
Figure 46. Germany AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 47. France AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 48. UK AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa AI in Pharmaceutical Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa AI in Pharmaceutical Market Size Market Share by Deployment Type (2021-2026)
Figure 53. Middle East & Africa AI in Pharmaceutical Market Size Market Share by Application (2021-2026)
Figure 54. Egypt AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries AI in Pharmaceutical Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 60. APAC AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 61. Europe AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 63. United States AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 64. Canada AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 65. Mexico AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 66. Brazil AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 67. China AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 68. Japan AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 69. Korea AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 71. India AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 72. Australia AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 73. Germany AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 74. France AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 75. UK AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 76. Italy AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 77. Russia AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 78. Egypt AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 79. South Africa AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 80. Israel AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 81. Turkey AI in Pharmaceutical Market Size 2027-2032 ($ millions)
Figure 82. Global AI in Pharmaceutical Market Size Market Share Forecast by Deployment Type (2027-2032)
Figure 83. Global AI in Pharmaceutical Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries AI in Pharmaceutical Market Size 2027-2032 ($ millions)
